TCI Wealth Advisors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-334
Closed -$3.05K 547
2023
Q1
$3.05K Buy
+334
New +$4.27K ﹤0.01% 1845
2021
Q4
Sell
-170
Closed -$11K 2319
2021
Q3
$11K Buy
170
+3
+2% +$228 ﹤0.01% 1022
2021
Q2
$15K Buy
167
+103
+161% +$8.19K ﹤0.01% 701
2021
Q1
$4K Buy
+64
New +$4.97K ﹤0.01% 1346

Other funds holding CDNA

TCI Wealth Advisors's CDNA Position: Q2 2023 in Review

TCI Wealth Advisors sold out of CareDx (CDNA) in Q2 2023, closing a stake of 334 shares — an estimated $3.05K sold.

TCI Wealth Advisors first reported a position in CDNA in Q1 2021 and held it in 4 quarters. The position peaked at $15K in Q2 2021. 154 funds tracked by Wall St. Rank hold CDNA as of Q2 2023.

  • TCI Wealth Advisors reported no remaining CareDx position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 334 CareDx shares in Q2 2023, an estimated $3.05K.
  • TCI Wealth Advisors first reported a position in CareDx in Q1 2021 and held it in 4 quarters.
  • TCI Wealth Advisors's CareDx position peaked at $15K in Q2 2021.
  • 154 funds tracked by Wall St. Rank held CareDx as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.